BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $147 | -64.2% | 22 | 0.0% | 0.00% | – |
| Q1 2023 | $411 | -79.4% | 22 | -77.1% | 0.00% | – |
| Q1 2022 | $2,000 | -96.7% | 96 | -95.2% | 0.00% | -100.0% |
| Q3 2021 | $61,000 | +306.7% | 2,000 | +300.0% | 0.02% | +433.3% |
| Q2 2021 | $15,000 | -54.5% | 500 | -34.4% | 0.00% | -57.1% |
| Q1 2021 | $33,000 | +266.7% | 762 | +314.1% | 0.01% | +250.0% |
| Q4 2020 | $9,000 | -89.7% | 184 | -90.8% | 0.00% | -91.7% |
| Q3 2020 | $87,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |